Open Access Open Access  Restricted Access Subscription or Fee Access

'Futuristic Spermbot' - Treatment of Cervical Cancer

Jayamoorthy Jayasri

Abstract


Cervical cancer is the second most common malignancy in wrold wide. India has a population of approximately 365.71 million women above 15 years of age, who are at risk of developing cervical cancer and leading cause of cancer death among Indian women and most cases of cervical cancer are caused by infection with human papillomavirus (HPV). A Research study conducted by Germany Scientists using Sperm cell as Spermbots in delivery chemotherapy directly towards the cancerous cells in the cervix by minimising serious side effect of chemotherapy. It has no side effect and operates at specific site only.Nano-Robots initial design cost is very high. The innovation in the field of Nanomedicines gives the hope for treatment in cervical cancer and improve the quaity of life of the patient in future

Full Text:

PDF

References


ICO Information Centre on HPV and Cancer India Human Papillomavirus and Related Cancers, Fact Sheet 2017 (2017-07-27) I. Key data on HPV and HPV-related cancers

ALLIZHEALTH “Cervical cancer prevention &control” Jan 11, 2017

Haifeng Xu (March 2017) “Sperm-hybrid micromotor for drug delivery in the female reproductive tract” ACS Nano(2017),DOI:10.1021/acsnano.7b06398

Hybrid Sperm may help combat cervical cancer, suggests study, ANI | Washington D.C. [U.S.A] Last Updated at December 25, 2017 14:00 IST

Harnessing sperm may help combat cervical cancer, Dec 24, 2017, 05.52 PM IST

First Published: Fri, Sep 30 2016. 11 30 PM IST in live mint 05 January 2018|E-Paper

Guston DH, editor. Encyclopedia of nanoscience and society. Sage; 2010 Jul 14.


Refbacks

  • There are currently no refbacks.